Campuses

As France's leading biocluster, Genopole is an incubator for cutting-edge projects in biotechnology. Located in the city of Évry, just south of Paris, Genopole provides a unique environment for scientists and entrepreneurs seeking to advance research and innovation.

Discover >

Advantages

Genopole accompanies researchers, postdocs and start-up entrepreneurs through all the phases of their projects to ensure the best possible conditions for business development.

Discover >

Genopole’s citizens

Every day, at Genopole, researchers, entrepreneurs and students cross paths, share ideas and unite forces in a veritable melting pot for innovation.

Discover >

Highlights

Giving wings to research and empowering employment in our community are cornerstones of Genopole's mission. Catch up on recent scientific advances, the accomplishments of our biotech actors and the events that enliven the biocluster.

Discover >

Innovate with us

Discover >
Company

Vaccinopole


LAboratory : BUilding 7 – 5, rue Henri Desbruères
91030 EVRY-COURCOURONNES Cedex – FRANCE
Phone : +33 1 78 05 47 27
Email : raymond.abolhassani@vaccinopole.fr

Raymond ABOLHASSANI : CEO
Vaccinopole - entreprise génopolitaine Vaccinopole - entreprise génopolitaine

#Health / Well-being #Therapeutics

  • BCG
  • Bladder cancer
  • tuberculosis
  • Colon Cancer
  • IBD
  • Covid – pulmonary infections

Field of Activity


Production of BCG vaccines and BCG-based cancer and inflammation treatments, preparation and distribution of fresh log-phase BCG cultures.

BACKGROUND
Vaccinopole proposes mouse and guinea pig models for anti-cancer, anti-asthma and anti-inflammatory screening.

As of this writing, the company has completed 37 pharmaceutical research projects. Since 2011, it has been manufacturing BCG (Mycobacterium bovis BCG) products in Asia.

DESCRIPTION OF THE PRODUCTS / SERVICES / TECHNOLOGY
Thanks to its exceptional process (surface culture) for the industrial production of BCG, Vaccinopole has produced and distributed more than 20 million doses of BCG vaccine to prevent tuberculosis and 150,000 vials of intravesical BCG to treat superficial bladder cancer.

The company develops novel formulations for US patenting at Institut Pasteur Paris, taking aim at such diseases as invasive bladder cancer, colon cancer or inflammatory bowel disease.

Unprecedentedly in Europe, Vaccinopole is now preparing fresh log-phase BCG cultures for urology/oncology hospital practitioners.

 

 

ACCOMPLISHMENTS / COLLABORATIONS / HIGHLIGHTS
Because BCG has been shown to control lung inflammation and reduce mortality in COVID-19 pulmonary infection in more than 120 articles and two clinical trials, Vaccinopole is currently developing a new BCG formulation for intradermal injection to protect adults from this pandemic disease.

Whether for the preparation of seed lots, formulations, the development of lyophilization parameters, the technical training of production personnel, or the conceptualization of industrial-scale standard operating procedures (production, formulation, filling and packaging, quality control and assurance), Vaccinopole partners with international centers for research and production in the settings of tuberculosis and urological cancers.

COLLABORATIONS SOUGHT
Respecting its humanitarian mission of eradicating tuberculosis worldwide and benefiting from its high-yield mycobacteria culturing technology, Vaccinopole is looking to transfer its know-how in the industrial production of BCG vaccines to countries across the world, while respecting local economic, geographic and commercial conditions.

 

  • Further Information

    €840,000 in sales

    4 Patents
    3 Staff members

    STRENGTHS
    High-yield culturing technology, novel technology in bacterial freeze drying.

    GMP-compliant industrial production of vaccines, standard procedures for human vaccine quality control and assurance.

Adresses

Head office

3, Square Auguste Renoir
75014 Paris
France

Laboratory

5, rue Henri Desbruères,
Genopole Campus 1,
91030 Evry-Courcouronnes
France

Agency

2, Chemin de Crève-Coeur
10380 Plancy l’Abbaye
France

Share
Genopole’s Companies

#Health / Well-being


In same field

DeepTope - Genopole's company

Deeptope

– Characterization of antigen / antibody interactions (epitope / paratope) – Optimization of therapeutic antibodies

Discover
Theranovir - Genopole's Company

Theranovir

Biotechnology, R&D, Drug development, oncology, obesity, infectious diseases

Discover
Cell Environment - Genopole's company

Cell Environment

Cell Environment is a company focusing on DNA damage detection involving unique and repeated sequences such as telomere and centromere sequences.

Discover
Innovhem - Entreprise génopolitaine

Innovhem

Our mission is to improve the management of Red Blood Cell diseases and in particular Sickle Cell Disease

Discover
Whitelab Genomics - Genopole's Company

WhiteLab Genomics

Artificial intelligence to optimize and accelerate the development of gene therapies

Discover
Traaser - Genopole's Company

TRaaSer

Software for biomedical data analysis

Discover
Synsight - Genopole's Company

Synsight

Synsight is a company specializing in the discovery and preclinical development of new therapeutic molecules, based on a proprietary, integrated platform, combining artificial intelligence, molecular modeling and a functional experimental screening approach of High-Content Screening (HCS ).

Discover
Sebia - Genopole's Company

Sebia

Design, manufacture and commercialization of in vitro diagnostic systems (instruments and reagents) for medical biology laboratories.

Discover
Santen - Genopole's Company

Santen

Santen SAS has developed its own sales force to commercialize ophthalmic products in France while Novagali Innovation Center is a center of excellence for Santen Group dedicated to research and development of innovative ophthalmic treatments for all segments of the eye.

Discover
Pharnext - Genopole's company

Pharnext SA

Pharnext develops new therapies and biomarkers based on network pharmacology with a proprietary discovery platform. The company is focused on pathologies with high unmet medical needs. These include neurodegenerative, orphan and common diseases (Charcot-Marie-Tooth disease Type 1A, Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS)).

Discover
PEP-Therapy - Genopole's Company - logo 2021

PEP-Therapy

PEP-Therapy develops innovative peptides as targeted therapies in oncology. The company operates a unique therapeutic technology based on cell penetrating & interfering peptides (CP&IP). These innovative molecules penetrate cells and specifically block relevant intracellular protein-protein interactions, thus inhibiting key pathological mechanisms.

Discover
LPS Biosciences - Genopole's company

LPS-BioSciences

LPS-BioSciences is specialized in bacterial endotoxins. It combines an exclusive proprietary technology for endotoxin production and characterization. and its acquired experience in the fields of vaccines, diagnostics, and the food industry.

Discover
Logo Integragen - Genopole's Company

Integragen

IntegraGen’s mission is to translate molecular research to clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on these discoveries.

Discover
Généthon - Genopole's Laboratory

Généthon

Discovery, development and production of innovative therapies for rare genetic diseases, notably neuromuscular diseases.

Discover
Enterome - Genopole's company

Enterome

Enterome develops and commercializes therapies for disorders associated with disruption of the intestinal microbiota.

Discover
Endodiag - Genopole's company

Endodiag

Design, development and commercialization of medical devices and services for the diagnosis of endometriosis.

Discover
Enalees - Genopole's company

Enalees

Enalees conceives, develops and markets next-generation rapid molecular diagnosis tests for veterinarians, and furthermore screening tests for SARS-CoV-2.

Discover
Algobiotech - Genopole's company

Algobiotech

Research and valorization of microalgae for cosmetic, nutraceutic and therapeutic applications.

Discover
AiiNTENSE - Genopole's company

AiiNTENSE

AiiNTENSE provides a complete cognitive assistance solution to improve the medical, ethical and economic management of patients in intensive care units.

Discover
logo abcell Bio - Genopole's Companie

ABCell-Bio

Abcell-bio is a laboratory specializing in the isolation of human hematopoietic stem cells and primary cells derived from perinatal tissue and cord blood.

Discover
View all >
With the support from